| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Aigli G Vakrakou, Maria-Evgenia Brinia, Ioanna Svolaki, Theodore Argyrakos, Leonidas Stefanis, Constantinos Kilidirea. Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases. Frontiers in neurology. vol 13. 2022-04-14. PMID:35418930. |
tdl can emerge not only as part of the spectrum of classic multiple sclerosis (ms) but also can represent an idiopathic monophasic disease, a relapsing disease with recurrent tdl, or could be part of the myelin oligodendrocyte glycoprotein (mog)- and aquaporin-4 (aqp4)-associated disease. |
2022-04-14 |
2023-08-13 |
Not clear |
| Jae-Won Hyun, Yeseul Kim, Ki Hoon Kim, Su-Hyun Kim, Mads Nikolaj Olesen, Nasrin Asgari, Sasitorn Siritho, Friedemann Paul, Ho Jin Ki. CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage. Journal of neuroinflammation. vol 19. issue 1. 2022-04-13. PMID:35413922. |
despite rigorous confirmation with reliable assays, some individuals showing the neuromyelitis optica spectrum disorder (nmosd) phenotype remain negative for both aquaporin-4 (aqp4) and myelin oligodendrocyte glycoprotein (mog) antibodies. |
2022-04-13 |
2023-08-13 |
Not clear |
| Ellen Yang, Adnan Husein, Jose Martinez-Perez, Terrence L. Post-COVID-19 Longitudinally Extensive Transverse Myelitis with Myelin Oligodendrocyte Glycoprotein Antibodies. Case reports in neurological medicine. vol 2022. 2022-04-11. PMID:35399911. |
myelin oligodendrocyte glycoprotein (mog) antibody disease most commonly presents with optic neuritis, though myelitis is also possible. |
2022-04-11 |
2023-08-13 |
Not clear |
| Alessandro Dinoto, Elia Sechi, Eoin P Flanagan, Sergio Ferrari, Paolo Solla, Sara Mariotto, John J Che. Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease. Frontiers in neurology. vol 13. 2022-04-11. PMID:35401423. |
more recently, antibodies against myelin oligodendrocyte glycoprotein (mog-igg), have been found to be a biomarker of a different entity, termed mog antibody-associated disease (mogad), which has overlapping, but different pathogenesis, clinical features, treatment response, and prognosis when compared to aqp4-igg-positive nmosd. |
2022-04-11 |
2023-08-13 |
Not clear |
| Andrew J Martin, James Strathdee, Nigel Wolf. Coexistent anti-GFAP and anti-MOG antibodies presenting with isolated meningitis and papillitis: more support for overlapping pathophysiology. BMJ neurology open. vol 4. issue 1. 2022-04-11. PMID:35402916. |
anti-myelin oligodendrocyte glycoprotein (mog)-associated disorders are heterogeneous and associated predominantly with central nervous system demyelination. |
2022-04-11 |
2023-08-13 |
Not clear |
| Junxia Fu, Yongping Wang, Hongen Li, Huanfen Zhou, Honglu Song, Mingming Sun, Quangang Xu, Shaoying Tan, Shihui We. Efficacy of Plasma Exchange Treatment for Demyelinating Optic Neuritis Associated with Various Serum Antibodies: A Prospective Cohort Study. Neurology and therapy. 2022-04-09. PMID:35397098. |
to evaluate the value of plasma exchange (pe) for patients with three subtypes of demyelinating optic neuritis (on): aquaporin-4 (aqp4) antibody-positive on (aqp4-on), myelin oligodendrocyte glycoprotein (mog) antibody-positive on (mog-on), and aqp4 and mog double-antibody-seronegative on (d-on). |
2022-04-09 |
2023-08-13 |
Not clear |
| Kentaro Tokumoto, Takuji Nishida, Norihiko Kawaguchi, Kimihiko Kaneko, Toshiyuki Takahashi, Yukitoshi Takahash. Electroclinical features of seizures in myelin oligodendrocyte glycoprotein antibody-associated cerebral cortical encephalitis: A case report and literature review. Seizure. vol 98. 2022-04-09. PMID:35397246. |
myelin oligodendrocyte glycoprotein (mog) antibodies (abs) are associated with various central nervous system demyelinating disorders. |
2022-04-09 |
2023-08-13 |
Not clear |
| Sonya Bells, Giulia Longoni, Tara Berenbaum, Cynthia B de Medeiros, Sridar Narayanan, Brenda L Banwell, Douglas L Arnold, Donald J Mabbott, E Ann Ye. Patterns of white and gray structural abnormality associated with paediatric demyelinating disorders. NeuroImage. Clinical. vol 34. 2022-04-05. PMID:35381508. |
the impact of multiple sclerosis (ms) and myelin oligodendrocyte glycoprotein (mog) - associated disorders (mogad) on brain structure in youth remains poorly understood. |
2022-04-05 |
2023-08-13 |
Not clear |
| Kyoko Maruta, Yasuyuki Nobuhara, Yuji Ijiri, Fumikazu Kojima, Hiroshi Takashim. [Right optic perineuritis and myelitis 6 years following left optic perineuritis in anti-myelin oligodendrocyte glycoprotein-associated disorder: a case report]. Rinsho shinkeigaku = Clinical neurology. 2022-03-31. PMID:35354728. |
we report a patient with myelin oligodendrocyte glycoprotein (mog) antibody positivity who manifested myelitis with right optic perineuritis (opn) 6 years following left opn. |
2022-03-31 |
2023-08-13 |
Not clear |
| Sabine Tacke, Rittika Chunder, Verena Schropp, Eduard Urich, Stefanie Kuerte. Effects of a Fully Humanized Type II Anti-CD20 Monoclonal Antibody on Peripheral and CNS B Cells in a Transgenic Mouse Model of Multiple Sclerosis. International journal of molecular sciences. vol 23. issue 6. 2022-03-25. PMID:35328594. |
male hcd20xhigr3 mice and wild-type c57bl/6 (b6) mice were immunized with human myelin oligodendrocyte glycoprotein (mog) |
2022-03-25 |
2023-08-13 |
mouse |
| Tianxin Yao, Qianqian Zeng, Yuanyuan Xie, Fangfang Bi, Le Zhang, Bo Xiao, Jinxia Zho. Clinical analysis of adult MOG antibody-associated cortical encephalitis. Multiple sclerosis and related disorders. vol 60. 2022-03-23. PMID:35320766. |
to describe the clinical and neuroimaging features, treatment response and outcomes of adult myelin oligodendrocyte glycoprotein (mog) antibody-associated cortical encephalitis. |
2022-03-23 |
2023-08-13 |
Not clear |
| Yuki Matsumoto, Ayane Ohyama, Takafumi Kubota, Kensuke Ikeda, Kimihiko Kaneko, Yoshiki Takai, Hitoshi Warita, Toshiyuki Takahashi, Tatsuro Misu, Masashi Aok. MOG Antibody-Associated Disorders Following SARS-CoV-2 Vaccination: A Case Report and Literature Review. Frontiers in neurology. vol 13. 2022-03-18. PMID:35299613. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated disorder (mogad) is a newly identified autoimmune demyelinating disorder that is often associated with acute disseminated encephalomyelitis and usually occurs postinfection or postvaccination. |
2022-03-18 |
2023-08-13 |
Not clear |
| Malgorzata Wolska-Krawczy. [Acute disseminated encephalomyelitis]. Der Radiologe. 2022-03-15. PMID:35290492. |
according to the guidelines, adem belongs to the myelin oligodendrocyte glycoprotein (mog)-associated diseases and usually manifests after febrile infections (also after sars-cov-2) or postvaccinally. |
2022-03-15 |
2023-08-13 |
Not clear |
| Daniela Ximena Rojas-Correa, José Alberto Reche-Sainz, Alfredo Insausti-García, Cristina Calleja-García, Manuel Ferro-Osun. Post COVID-19 Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis. Neuro-ophthalmology (Aeolus Press). vol 46. issue 2. 2022-03-11. PMID:35273416. |
he tested positive for sars-cov-2 igg and myelin oligodendrocyte glycoprotein (mog) igg antibodies. |
2022-03-11 |
2023-08-13 |
Not clear |
| Vyanka Redenbaugh, Eoin P Flanaga. Monoclonal Antibody Therapies Beyond Complement for NMOSD and MOGAD. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2022-03-10. PMID:35267170. |
aquaporin-4 (aqp4)-igg seropositive neuromyelitis optica spectrum disorders (aqp4-igg seropositive nmosd) and myelin oligodendrocyte glycoprotein (mog)-igg-associated disease (mogad) are inflammatory demyelinating disorders distinct from each other and from multiple sclerosis (ms).while anti-cd20 treatments can be used to treat ms and aqp4-igg seropositive nmosd, some ms medications are ineffective or could exacerbate aqp4-igg seropositive nmosd including beta-interferons, natalizumab, and fingolimod. |
2022-03-10 |
2023-08-13 |
Not clear |
| Youssef El Khoury, Marie Gebelin, Jérôme de Sèze, Christine Patte-Mensah, Gilles Marcou, Alexandre Varnek, Ayikoé-Guy Mensah-Nyagan, Petra Hellwig, Nicolas Collongue. Rapid Discrimination of Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis Using Machine Learning on Infrared Spectra of Sera. International journal of molecular sciences. vol 23. issue 5. 2022-03-10. PMID:35269934. |
another target in nmosd is myelin oligodendrocyte glycoprotein (mog), delineating a new spectrum of diseases called mog-associated diseases. |
2022-03-10 |
2023-08-13 |
human |
| Shanchao Zhang, Shan Qiao, Haiyun Li, Ranran Zhang, Meiling Wang, Tao Han, Xuewu Liu, Yunshan Wan. Risk Factors and Nomogram for Predicting Relapse Risk in Pediatric Neuromyelitis Optica Spectrum Disorders. Frontiers in immunology. vol 13. 2022-03-07. PMID:35250969. |
however, some pediatric patients diagnosed with nmosds were tested to be positive for myelin oligodendrocyte glycoprotein (mog) antibody. |
2022-03-07 |
2023-08-13 |
Not clear |
| Louisa Nitsch, Simon Petzinna, Julian Zimmermann, Daniel R Getts, Albert Becker, Marcus Mülle. MOG-Specific T Cells Lead to Spontaneous EAE with Multilocular B Cell Infiltration in the GF-IL23 Model. Neuromolecular medicine. 2022-03-03. PMID:35239103. |
to further investigate the impact of cns-specific il-23-expression on neuroinflammation, we studied the gf-il23 model in mice expressing a myelin oligodendrocyte glycoprotein (mog)-specific t cell receptor (gf23-2d2 mice). |
2022-03-03 |
2023-08-13 |
mouse |
| Takuma Kato, Atsushi Yamamoto, Keisuke Imai, Kanako Menjo, Tetsuya Ioku, Daiki Takewak. [Anti-myelin oligodendrocyte glycoprotein antibody-positive unilateral cerebral cortical encephalitis occurring first as general convulsion after meningitis symptoms and second after headache]. Rinsho shinkeigaku = Clinical neurology. 2022-03-01. PMID:35228465. |
subsequently, headache exacerbated again and an additional examination for his serum sample taken on first admission day revealed presence of anti myelin oligodendrocyte glycoprotein (mog)-antibody, resulting in his diagnosis of anti-mog antibody unilateral cerebral cortical encephalitis (mog-ucce) on day 42. |
2022-03-01 |
2023-08-13 |
Not clear |
| Chaitali P Basole, Rebecca K Nguyen, Katie Lamothe, Puja Billis, Mai Fujiwara, Amanda G Vang, Robert B Clark, Paul M Epstein, Stefan Brock. Treatment of Experimental Autoimmune Encephalomyelitis with an Inhibitor of Phosphodiesterase-8 (PDE8). Cells. vol 11. issue 4. 2022-02-25. PMID:35203312. |
we have previously demonstrated a role for the pde8a-raf-1 kinase complex in the regulation of myelin oligodendrocyte glycoprotein peptide 35-55 (mog |
2022-02-25 |
2023-08-13 |
Not clear |